Cargando…
Effect of a Combination of Prednisone or Mycophenolate Mofetil and Mesenchymal Stem Cells on Lupus Symptoms in MRL.Fas(lpr) Mice
The combination of immunosuppressants and mesenchymal stem cells (MSCs) is a promising therapeutic strategy for systemic lupus erythematosus, since this approach reduces doses of immunosuppressants while maintaining the same therapeutic outcome. However, it is unavoidable for MSCs to be exposed to i...
Autores principales: | Lee, Hong Kyung, Kim, Ki Hun, Kim, Hyung Sook, Kim, Ji Sung, Lee, Jae Hee, Ji, Ayoung, Kim, Kyung Suk, Lee, Tae Yong, Chang, In Young, Bae, Sang-Cheol, Hong, Jin Tae, Kim, Youngsoo, Han, Sang-Bae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051060/ https://www.ncbi.nlm.nih.gov/pubmed/30057623 http://dx.doi.org/10.1155/2018/4273107 |
Ejemplares similares
-
Mesenchymal stem cells enhance CCL8 expression by podocytes in lupus-prone MRL.Fas(lpr) mice
por: Kim, Hyung Sook, et al.
Publicado: (2023) -
Effect of Human Mesenchymal Stem Cells on Xenogeneic T and B Cells Isolated from Lupus-Prone MRL.Fas(lpr) Mice
por: Lee, Hong Kyung, et al.
Publicado: (2020) -
Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in MRL.Fas(lpr) mice
por: Lee, Hong Kyung, et al.
Publicado: (2020) -
Murine lupus is neutrophil elastase-independent in the MRL.Fas(lpr) model
por: Gordon, Rachael A., et al.
Publicado: (2020) -
Mycophenolate-mofetil/prednisone/tacrolimus: Infections: case report
Publicado: (2020)